Related Experiment Video

Updated: Jul 2, 2026

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids
07:14

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids

Published on: May 16, 2025

Perspectives on the use of gene therapy for chronic joint diseases

Steven C Ghivizzani1, Elvire Gouze, Jean-Noel Gouze

  • 1Gene Therapy Laboratory, Department of Orthopaedics & Rehabilitation, University of Florida College of Medicine, Gainesville FL 32610, USA. ghivisc@ortho.ufl.edu

Current Gene Therapy
|August 12, 2008
PubMed

Insights

Gene therapy offers a promising approach to treat chronic joint diseases like arthritis by enabling the body to produce therapeutic proteins. This review explores gene transfer methods, their benefits, limitations, and challenges for clinical application.

Area of Science:

  • Molecular and cellular biology
  • Biotechnology
  • Rheumatology

Background:

  • Protein-based drugs show potential for treating chronic joint diseases like osteoarthritis and rheumatoid arthritis.
  • Challenges with protein drugs include poor administration, high turnover, and side effects from non-targeted exposure.
  • Gene transfer technologies present a novel solution for localized, sustained production of therapeutic proteins.

Purpose of the Study:

  • To review and condense studies on gene therapies for arthritis.
  • To discuss the benefits and limitations of various gene transfer methods.
  • To identify challenges in translating gene therapy for arthritis into clinical practice.

Main Methods:

  • Review of existing literature on gene therapy for arthritis.
  • Analysis of proof-of-concept studies in animal models.
  • Evaluation of different gene transfer techniques and their outcomes.

Main Results:

  • Gene therapy has demonstrated proof of concept for treating arthritis in numerous laboratory and animal studies.
  • Various gene transfer methods have been proposed, each with distinct advantages and disadvantages.
  • Significant challenges remain in the clinical translation of these promising technologies.

Conclusions:

  • Gene therapy holds significant potential for advancing the treatment of chronic joint diseases.
  • Overcoming challenges in delivery, efficacy, and safety is crucial for clinical success.
  • Further research and development are needed to bring gene therapies for arthritis to patients.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview